Global Hydroxychloroquine Market, Trends Size, By Drug Activity (Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, and Other Drug Activity), By Formulation (Tablets and Injection), By Application (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, and Other Applications), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Hydroxychloroquine Market 
The Global Hydroxychloroquine Market was valued at US$ 2.5 Bn in 2022, estimated to reach US$ 5.8 Bn by 2030, with a CAGR of 9.05% from 2023-2030.
Malaria is mostly treated and prevented using hydroxychloroquine (HCQ), a chemotherapy drug. It is frequently given orally as a tablet and is effective against erythrocytic malarial parasite strains. It is also used to treat conditions like systemic lupus erythematosus, rheumatoid arthritis, Q fever, and porphyria cutanea tarda (PCT), and clinical trials are being done to see if it may treat the rapidly developing COVID-19 disease. It suppresses immunological responses and causes the body to produce antigens and cytokines, making it immunosuppressive, anti-autophagic, and antimalarial.
Market Drivers
An increase in rheumatoid arthritis and malaria prevalence, as well as an increase in the number of elderly people, is anticipated to drive market growth. The global Hydroxychloroquine Market is anticipated to grow shortly due to an increase in new releases and approvals.
Furthermore, more product launches and product approvals are one of the factors propelling the market growth. Positive market effects are envisaged from rising generic medicine penetration and increased demand for novel hydroxychloroquine. For instance, Novartis International AG began supplying the U.S. Department of Health and Human Services (HHS) with 30 million doses of hydroxychloroquine tablets in March 2020 for controlled clinical trials to assess the effectiveness of hydroxychloroquine in patients with coronavirus infection.
Market Restraints
When coupled with medications that have comparable effects on the heart, such as the antibiotic azithromycin, chloroquine, and hydroxychloroquine have been reported to cause heart rhythm issues. If these issues are treated, they may become worse. The European Drugs Agency conducted research that supports this. When taken in large quantities, azithromycin has been linked to significant, and occasionally fatal, heart rhythm issues when paired with chloroquine or hydroxychloroquine. The market's rate of expansion will be slowed by this.
Market Segmentation
The scope of the Global Hydroxychloroquine Market covers segmentation based on Drug Activity, Formulation, Application, and Region.
Based on Drug Activity, the market is divided into Anti-Malarial Drugs, Anti-Rheumatic Drugs, Lupus Suppressant Drugs, Anti COVID-19 Drugs, and Other Drug Activity.
Based on Formulation, the market is classified into Tablets and Injections.
Based on Application, the market is bifurcated into Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, and Other Applications.
Regional Analysis
The Global Hydroxychloroquine Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America growing at a significant pace during the forecast period due to the increased patient awareness of disease-remitted therapy, an increase in the prevalence of RA and COVID-19, and high public and private healthcare spending. Furthermore, the World Health Organisation predicts that 54.4 million adults in the nation may have rheumatoid arthritis by the end of 2040. Additionally, it is anticipated that simple access to high-quality healthcare, kind reimbursement systems, a robust trial pipeline, and the approval of innovative pharmaceuticals will support revenue growth in North America.
The market in Asia-Pacific is anticipated to grow at the quickest rate over the forecast period. The number of patients in some impoverished countries is growing as a result of a lack of disease knowledge in those areas
Key Players
Cadila Healthcare Limited, Hikma Pharmaceuticals PLC, IPCA Laboratories Ltd, Mylan N.V, Novartis International AG, Pfizer Inc, Sanofi S.A, Taj Pharma Group, Teva Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Limited
Market Taxonomy
By Drug Activity
• Anti-Malarial Drug
• Anti-Rheumatic Drug
• Lupus Suppressant Drug
• Anti COVID-19 Drug
• Other Drug Activity
By Formulation
• Tablets
• Injection
By Application
• Malaria
• Rheumatoid Arthritis
• Lupus Erythematosus
• COVID-19
• Other Applications
By Region
• North America 
o U.S.
o Canada
o Mexico
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Europe
o Germany
o France
o UK
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China           
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Bonsai Market?
 
• What will be the growth rate from 2023 to 2030?
 
• Which segment/region will have the highest growth?
 
• What are the factors that will impact/drive the Market?
 
• What is the competitive Landscape in the Industry?

Global Hydroxychloroquine Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Hydroxychloroquine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Hydroxychloroquine Market, By Drug Activity
5.1 Y-o-Y Growth Comparison, By Drug Activity
5.2 Global Hydroxychloroquine Market Share Analysis, By Drug Activity
5.3 Global Hydroxychloroquine Market Size and Forecast, By Drug Activity
5.3.1 Anti-Malarial Drug
5.3.2 Anti-Rheumatic Drug
5.3.3 Lupus Suppressant Drug
5.3.4 Anti COVID-19 Drug
5.3.5 Other Drug Activity
6 Global Hydroxychloroquine Market, By Formulation 
6.1 Y-o-Y Growth Comparison, By Formulation
6.2 Global Hydroxychloroquine Market Share Analysis, By Formulation
6.3 Global Hydroxychloroquine Market Size and Forecast, By Formulation 
6.3.1 Tablets and Injection
6.3.2 Injection
Surgical Instruments Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Hydroxychloroquine Market Share Analysis, By Application
7.3 Global Hydroxychloroquine Market Size and Forecast, By Application
7.3.1 Malaria
7.3.2 Rheumatoid Arthritis
7.3.3 Lupus Erythematosus 
7.3.4 COVID-19
7.3.5 Other Applications
8 Global Hydroxychloroquine Market, By Region
8.1 Global Hydroxychloroquine Market Share Analysis, By Region
8.2 Global Hydroxychloroquine Market Size and Forecast, By Region
8.3 Global Hydroxychloroquine Market Trends and Forecast, By Region
9 North America Hydroxychloroquine Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Hydroxychloroquine Market Share Analysis, By Drug Activity
9.3 North America Hydroxychloroquine Market Size and Forecast, By Formulation 
9.4 North America Hydroxychloroquine Market Size and Forecast, By Application
9.5 North America Hydroxychloroquine Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Drug Activity
9.5.1.2 Market Size and Forecast, By Formulation
9.5.1.3 Market Size and Forecast, By Application
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Drug Activity
9.5.2.2 Market Size and Forecast, By Formulation
9.5.2.3 Market Size and Forecast, By Application
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Drug Activity
9.5.3.2 Market Size and Forecast, By Formulation
9.5.3.3 Market Size and Forecast, By Application
10 Europe Hydroxychloroquine Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Hydroxychloroquine Market Share Analysis, By Drug Activity
10.3 Europe Hydroxychloroquine Market Size and Forecast, By Formulation 
10.4 Europe Hydroxychloroquine Market Size and Forecast, By Application
10.5 Europe Hydroxychloroquine Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Drug Activity
10.5.1.2 Market Size and Forecast, By Formulation
10.5.1.3 Market Size and Forecast, By Application
10.5.2 France
10.5.2.1 Market Size and Forecast, By Drug Activity
10.5.2.2 Market Size and Forecast, By Formulation
10.5.2.3 Market Size and Forecast, By Application
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Drug Activity
10.5.3.2 Market Size and Forecast, By Formulation
10.5.3.3 Market Size and Forecast, By Application
10.5.4. Russia 
10.5.4.1 Market Size and Forecast, By Drug Activity
10.5.4.2 Market Size and Forecast, By Formulation
10.5.4.3 Market Size and Forecast, By Application
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Drug Activity
10.5.5.2 Market Size and Forecast, By Formulation
10.5.5.3 Market Size and Forecast, By Application
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Drug Activity
10.5.6.2 Market Size and Forecast, By Formulation
10.5.6.3 Market Size and Forecast, By Application
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Drug Activity
10.5.7.2 Market Size and Forecast, By Formulation
10.5.7.3 Market Size and Forecast, By Application
11 Asia Pacific Hydroxychloroquine Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Hydroxychloroquine Market Share Analysis, By Drug Activity
11.3 Asia Pacific Hydroxychloroquine Market Size and Forecast, By Formulation 
11.4 Asia Pacific Hydroxychloroquine Market Size and Forecast, By Application
11.5 Asia Pacific Hydroxychloroquine Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Drug Activity
11.5.1.2 Market Size and Forecast, By Formulation
11.5.1.3 Market Size and Forecast, By Application
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Drug Activity
11.5.2.2 Market Size and Forecast, By Formulation
11.5.2.3 Market Size and Forecast, By Application
11.5.3 India
11.5.3.1 Market Size and Forecast, By Drug Activity
11.5.3.2 Market Size and Forecast, By Formulation
11.5.3.3 Market Size and Forecast, By Application
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Drug Activity
11.5.4.2 Market Size and Forecast, By Formulation
11.5.4.3 Market Size and Forecast, By Application
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Drug Activity
11.5.5.2 Market Size and Forecast, By Formulation
11.5.5.3 Market Size and Forecast, By Application
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Drug Activity
11.5.6.2 Market Size and Forecast, By Formulation
11.5.6.3 Market Size and Forecast, By Application
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Drug Activity
11.5.7.2 Market Size and Forecast, By Formulation
11.5.7.3 Market Size and Forecast, By Application
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Drug Activity 
11.5.8.2 Market Size and Forecast, By Formulation
11.5.8.3 Market Size and Forecast, By Application
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Drug Activity
11.5.9.2 Market Size and Forecast, By Formulation
11.5.9.3 Market Size and Forecast, By Application
12 Latin America Hydroxychloroquine Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Hydroxychloroquine Market Share Analysis, By Drug Activity
12.3 Latin America Hydroxychloroquine Market Size and Forecast, By Formulation 
12.4 Latin America Hydroxychloroquine Market Size and Forecast, By Application
12.5 Latin America Hydroxychloroquine Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Drug Activity
12.5.1.2 Market Size and Forecast, By Formulation
12.5.1.3 Market Size and Forecast, By Application
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Drug Activity
12.5.2.2 Market Size and Forecast, By Formulation
12.5.2.3 Market Size and Forecast, By Application
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Drug Activity 
12.5.3.2 Market Size and Forecast, By Formulation
12.5.3.3 Market Size and Forecast, By Application
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Drug Activity
12.5.4.2 Market Size and Forecast, By Formulation
12.5.4.3 Market Size and Forecast, By Application
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Drug Activity
12.5.5.2 Market Size and Forecast, By Formulation
12.5.5.3 Market Size and Forecast, By Application
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Drug Activity
12.5.6.2 Market Size and Forecast, By Formulation
12.5.6.3 Market Size and Forecast, By Application
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Drug Activity
12.5.7.2 Market Size and Forecast, By Formulation
12.5.7.3 Market Size and Forecast, By Application
13 Middle East Hydroxychloroquine Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Hydroxychloroquine Market Share Analysis, By Drug Activity
13.3 Middle East Hydroxychloroquine Market Size and Forecast, By Formulation 
13.4 Middle East Hydroxychloroquine Market Size and Forecast, By Application
13.5 Middle East Hydroxychloroquine Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Drug Activity
13.5.1.2 Market Size and Forecast, By Formulation
13.5.1.3 Market Size and Forecast, By Application
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Drug Activity
13.5.2.2 Market Size and Forecast, By Formulation
13.5.2.3 Market Size and Forecast, By Application
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Drug Activity 
13.5.3.2 Market Size and Forecast, By Formulation
13.5.3.3 Market Size and Forecast, By Application
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Application
13.5.4.2 Market Size and Forecast, By Formulation
13.5.4.3 Market Size and Forecast, By Application
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Drug Activity
13.5.5.2 Market Size and Forecast, By Formulation
13.5.5.3 Market Size and Forecast, By Application
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Drug Activity 
13.5.6.2 Market Size and Forecast, By Formulation
13.5.6.3 Market Size and Forecast, By Drug Activity-
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Cadila Healthcare Limited
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Hikma Pharmaceuticals PLC
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 IPCA Laboratories Ltd
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Mylan N.V
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Novartis International AG
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Pfizer Inc
1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Sanofi S.A
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Taj Pharma Group
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Teva Pharmaceutical Industries Ltd
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Torrent Pharmaceuticals Limited
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies